Ichino M, Mor G, Conover J, Weiss W R, Takeno M, Ishii K J, Klinman D M
Section of Retroviral Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
J Immunol. 1999 Apr 1;162(7):3814-8.
A plasmid DNA vaccine encoding the circumsporozoite protein of malaria (pCSP) induces tolerance rather than immunity when administered to newborn mice. We find that this tolerance persists for >1 yr after neonatal pCSP administration and interferes with the induction of protective immunity in animals challenged with live sporozoites. Susceptibility to tolerance induction wanes rapidly with age, disappearing within 1 wk of birth. Higher doses of plasmid are more tolerogenic, and susceptibility to tolerance is not MHC-restricted. CD8+ T cells from tolerant mice suppress the in vitro Ag-specific immune response of cells from adult mice immunized with pCSP. Similarly, CD8+ T cells from tolerant mice transfer nonresponsiveness to naive syngeneic recipients. These findings clarify the cellular basis and factors contributing to the development of DNA vaccine-induced neonatal tolerance.
编码疟疾环子孢子蛋白的质粒DNA疫苗(pCSP)在给予新生小鼠时会诱导耐受而非免疫。我们发现,这种耐受在新生期给予pCSP后持续超过1年,并干扰用活子孢子攻击的动物中保护性免疫的诱导。诱导耐受的易感性随年龄迅速减弱,在出生后1周内消失。更高剂量的质粒更具耐受性,且耐受易感性不受主要组织相容性复合体(MHC)限制。来自耐受小鼠的CD8 + T细胞抑制用pCSP免疫的成年小鼠细胞的体外抗原特异性免疫反应。同样,来自耐受小鼠的CD8 + T细胞将无反应性转移给同基因的未致敏受体。这些发现阐明了DNA疫苗诱导的新生期耐受发展的细胞基础和相关因素。